ID: ALA4159158

Max Phase: Preclinical

Molecular Formula: C51H61N7O6

Molecular Weight: 868.09

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCn1cc(C[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC)C(=O)N[C@@H](CC(C)C)C(=O)O)c2ccccc21

Standard InChI:  InChI=1S/C51H61N7O6/c1-5-6-25-58-32-37(39-22-14-16-24-46(39)58)30-44(50(62)57-45(51(63)64)26-33(2)3)56-48(60)42(28-35-19-11-8-12-20-35)54-49(61)43(29-36-31-53-40-23-15-13-21-38(36)40)55-47(59)41(52-4)27-34-17-9-7-10-18-34/h7-24,31-33,41-45,52-53H,5-6,25-30H2,1-4H3,(H,54,61)(H,55,59)(H,56,60)(H,57,62)(H,63,64)/t41-,42+,43-,44-,45+/m1/s1

Standard InChI Key:  OLCXGQPDICIEHO-VSOUDBLZSA-N

Associated Targets(Human)

NCI-H69 709 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DMS-79 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 868.09Molecular Weight (Monoisotopic): 867.4683AlogP: 5.85#Rotatable Bonds: 23
Polar Surface Area: 186.45Molecular Species: ACIDHBA: 7HBD: 7
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 4
CX Acidic pKa: 3.89CX Basic pKa: 8.34CX LogP: 4.86CX LogD: 4.82
Aromatic Rings: 6Heavy Atoms: 64QED Weighted: 0.04Np Likeness Score: -0.13

References

1. Haitham Abusara O, Freeman S, Aojula HS..  (2017)  Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain.,  137  [PMID:28595067] [10.1016/j.ejmech.2017.05.053]

Source